Related references
Note: Only part of the references are listed.Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
Masae Iwasaki et al.
INFLAMMATION (2021)
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial
Eli Mansour et al.
TRIALS (2021)
Neurolysin substrates bradykinin, neurotensin and substance P enhance brain microvascular permeability in a human in vitro model
Abraham J. Al-Ahmad et al.
JOURNAL OF NEUROENDOCRINOLOGY (2021)
Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients
Simone R. Potje et al.
LIFE SCIENCES (2021)
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19?
Vardan T. Karamyan
PHYSIOLOGICAL REPORTS (2021)
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
Ashwin Kumar Shukla et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2021)
Bradykinin signaling regulates solute permeability and cellular junction organization in lymphatic endothelial cells
Sybille Kempe et al.
MICROCIRCULATION (2020)
Kinin B1 Receptor Blockade Prevents Angiotensin II-induced Neuroinflammation and Oxidative Stress in Primary Hypothalamic Neurons
Rohan Umesh Parekh et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock
Jonathan H. Chow et al.
ANESTHESIA AND ANALGESIA (2020)
COVID-19 cytokine storm: The anger of inflammation
Mehdi Mahmudpour et al.
CYTOKINE (2020)
Noscapine, a possible drug candidate for attenuation of cytokine release associated with SARS-CoV-2
Soltan A. Ebrahimi
DRUG DEVELOPMENT RESEARCH (2020)
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications
Joseph A. Roche et al.
FASEB JOURNAL (2020)
Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight?
Seyed-Mohammad Ghahestani et al.
IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY (2020)
Kallikrein-kinin system and oxidative stress in cisplatin-induced ovarian toxicity
Laura Silveira Ayres et al.
REPRODUCTIVE TOXICOLOGY (2020)
What would Sergio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Lucas A. D. Nicolau et al.
MEDICAL HYPOTHESES (2020)
A comprehensive review on drug repositioning against coronavirus disease 2019 (COVID19)
Maryam Rameshrad et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
A lesson from a saboteur: High-MW kininogen impact in coronavirus-induced disease 2019
Chiara Colarusso et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
Michael R. Garvin et al.
ELIFE (2020)
Hypertension prevalence in human coronavirus disease: the role of ACE system in infection spread and severity
Gaetano Ruocco et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19
Frank L. van de Veerdonk et al.
JAMA NETWORK OPEN (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study
Marco Falcone et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Review of icatibant use in the Winnipeg Regional Health Authority
George Cai et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)
2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
Jun She et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Prasun K. Datta et al.
THERANOSTICS (2020)
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne et al.
FRONTIERS IN IMMUNOLOGY (2019)
Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration
Chhinder P. Sodhi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Depolarizing Effectors of Bradykinin Signaling in Nociceptor Excitation in Pain Perception
Seung-In Choi et al.
BIOMOLECULES & THERAPEUTICS (2018)
Kinin B1 Receptor Inhibition With BI113823 Reduces Inflammatory Response, Mitigates Organ Injury, and Improves Survival Among Rats With Severe Sepsis
Priya Murugesan et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Bradykinin: Inflammatory Product of the Coagulation System
Zonne Hofman et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)
Preparation and preliminary characterization of recombinant neurolysin for in vivo studies
Naomi J. Wangler et al.
JOURNAL OF BIOTECHNOLOGY (2016)
A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems
Alvin H. Schmaier
FRONTIERS IN MEDICINE (2016)
A Randomized Trial of Icatibant in ACE-Inhibitor-Induced Angioedema
Murat Bas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vascular endothelial dysfunction and pharmacological treatment
Jin Bo Su
WORLD JOURNAL OF CARDIOLOGY (2015)
The Extreme Anterior Domain Is an Essential Craniofacial Organizer Acting through Kinin-Kallikrein Signaling
Laura Jacox et al.
CELL REPORTS (2014)
Decreased Neprilysin and Pulmonary Vascular Remodeling in Chronic Obstructive Pulmonary Disease
Marilee J. Wick et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Icatibant
Eline A. Dubois et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Neutrophil serine proteases: specific regulators of inflammation
Christine T. N. Pham
NATURE REVIEWS IMMUNOLOGY (2006)
Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors
ZL Chen et al.
HYPERTENSION (2005)
International union of pharmacology.: XLV.: Classification of the kinin receptor family:: from molecular mechanisms to pathophysiological consequences
LMF Leeb-Lundberg et al.
PHARMACOLOGICAL REVIEWS (2005)
Products of angiotensin I hydrolysis by human cardiac enzymes potentiate Bradykinin
EG Erdös et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Bradykinin-mediated angioedema
J Nussberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Recombinant human neutral endopeptidase ameliorates pancreatic elastase-induced lung injury
AM Lightner et al.
SURGERY (2002)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
